Pembrolizumab versus ipilimumab for advanced melanoma: Final overall survival analysis of KEYNOTE-006
Schachter, Jacob, Ribas, Antoni, Long, Georgina V., Arance, Ana, Grob, Jean Jacques, Mortier, Laurent, Daud, Adil, Carlino, Matteo S., McNeil, Catriona M., Lotem, Michal, Larkin, James M. G., Lorigan, Paul, Neyns, Bart, Blank, Christian U., Petrella, Teresa M., Hamid, Omid, Zhou, Honghong, Ebbinghaus, Scot, Ibrahim, Nageatte, Robert, Caroline
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article